Financials
- Market Capitalization 301.1 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-19.75
Relación precio/flujo de caja
0.6
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3116 | EBS Emergent BioSolutions Inc. Common Stock | 7.51 USD | -6.24% | -7.74% | -9.52% | -29.94% | 387.49 M USD | ||
| 3143 | AKBA Akebia Therapeutics, Inc. - Common Stock | 1.40 USD | +1.45% | +3.70% | +52.17% | +18.64% | 375.56 M USD | ||
| 3371 | TKNO Alpha Teknova, Inc. - Common Stock | 5.41 USD | 0.00% | +1.31% | +31.63% | +22.95% | 290.05 M USD | ||
| 3492 | SIGA SIGA Technologies Inc. - Common Stock | 3.42 USD | -5.26% | -6.56% | -21.02% | -59.76% | 245.30 M USD |